We're taking a closer look at Teladoc Health today, as the chatter surrounding the stock has increased notably in the last few weeks. Today, its shares moved -1.9% compared to 0.0% for the S&P 500. Increased investor interest and volatility surrounding the stock are not reason enough to buy in -- you should first perform your own due diligence. Here are some figures that can get you started:
-
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally.
-
Teladoc Health has moved -30.0% over the last year compared to 15.0% for the S&P 500 -- a difference of -45.0%
-
TDOC has an average analyst rating of hold and is -26.57% away from its mean target price of $30.0 per share
-
Its trailing 12 month earnings per share (EPS) is $-24.87
-
Teladoc Health has a trailing 12 month Price to Earnings (P/E) ratio of -0.9 while the S&P 500 average is 15.97
-
Its forward earnings per share (EPS) is $-1.14 and its forward P/E ratio is -19.3
-
TDOC has a Price to Earnings Growth (PEG) ratio of 0.22, which shows the company is very undervalued compared to its earnings growth estimates.
-
The company has a Price to Book (P/B) ratio of 1.58 in contrast to the S&P 500's average ratio of 2.95
-
Teladoc Health is part of the Health Care sector, which has an average P/E ratio of 24.45 and an average P/B of 4.16
-
Teladoc Health has on average reported free cash flows of $59.0 Million over the last four years, during which time they have grown by an an average of 0.0%